Genflow Biosciences (GENF) Competitors GBX 1.80 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitors GENF vs. OBI, OKYO, AOR, HEMO, RLM, NSCI, ONC, OPTI, SNG, and CIZShould you be buying Genflow Biosciences stock or one of its competitors? The main competitors of Genflow Biosciences include Ondine Biomedical (OBI), OKYO Pharma (OKYO), AorTech International (AOR), Hemogenyx Pharmaceuticals (HEMO), Realm Therapeutics (RLM), NetScientific (NSCI), Oncimmune (ONC), OptiBiotix Health (OPTI), Synairgen (SNG), and Cizzle Biotechnology (CIZ). These companies are all part of the "biotechnology" industry. Genflow Biosciences vs. Ondine Biomedical OKYO Pharma AorTech International Hemogenyx Pharmaceuticals Realm Therapeutics NetScientific Oncimmune OptiBiotix Health Synairgen Cizzle Biotechnology Genflow Biosciences (LON:GENF) and Ondine Biomedical (LON:OBI) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, community ranking, institutional ownership, analyst recommendations, risk, media sentiment, dividends, earnings and valuation. Does the media favor GENF or OBI? In the previous week, Ondine Biomedical had 2 more articles in the media than Genflow Biosciences. MarketBeat recorded 2 mentions for Ondine Biomedical and 0 mentions for Genflow Biosciences. Genflow Biosciences' average media sentiment score of 0.00 equaled Ondine Biomedical'saverage media sentiment score. Company Overall Sentiment Genflow Biosciences Neutral Ondine Biomedical Neutral Which has more volatility and risk, GENF or OBI? Genflow Biosciences has a beta of 2.37, suggesting that its share price is 137% more volatile than the S&P 500. Comparatively, Ondine Biomedical has a beta of 0.1, suggesting that its share price is 90% less volatile than the S&P 500. Which has higher valuation and earnings, GENF or OBI? Genflow Biosciences has higher earnings, but lower revenue than Ondine Biomedical. Ondine Biomedical is trading at a lower price-to-earnings ratio than Genflow Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGenflow BiosciencesN/AN/A-£1.53M-£0.01-180.00Ondine Biomedical£1.63M14.89-£14.27M-£0.03-291.67 Is GENF or OBI more profitable? Ondine Biomedical has a net margin of 0.00% compared to Genflow Biosciences' net margin of -256.07%. Genflow Biosciences' return on equity of -118.88% beat Ondine Biomedical's return on equity.Company Net Margins Return on Equity Return on Assets Genflow Biosciences-256.07% -118.88% -58.66% Ondine Biomedical N/A -685.59%-159.71% Do insiders and institutionals hold more shares of GENF or OBI? 9.2% of Genflow Biosciences shares are owned by institutional investors. Comparatively, 20.6% of Ondine Biomedical shares are owned by institutional investors. 64.2% of Genflow Biosciences shares are owned by company insiders. Comparatively, 36.7% of Ondine Biomedical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the MarketBeat Community believe in GENF or OBI? Ondine Biomedical received 1 more outperform votes than Genflow Biosciences when rated by MarketBeat users. CompanyUnderperformOutperformGenflow BiosciencesN/AN/AOndine BiomedicalOutperform Votes1100.00% Underperform VotesNo Votes Do analysts recommend GENF or OBI? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Genflow Biosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AOndine Biomedical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A SummaryGenflow Biosciences beats Ondine Biomedical on 7 of the 12 factors compared between the two stocks. Ad The Freeport SocietyMusk warns humanity: “Obsolete”The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern border is a travesty, but the 'invasion' I've found will have 10 times greater effects on our economy, and ultimately our way of life.Go here to see why. Get Genflow Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GENF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GENF vs. The Competition Export to ExcelMetricGenflow BiosciencesBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£6.30M£159.96M£5.39B£1.56BDividend YieldN/A3.39%5.13%11.24%P/E Ratio-180.00348.23114.371,707.53Price / SalesN/A19,593.161,489.56226,865.74Price / Cash3.0011.1439.6735.60Price / BookN/A7.754.662.85Net Income-£1.53M-£18.69M£119.06M£144.51M7 Day PerformanceN/A0.02%0.80%0.11%1 Month Performance-13.04%2.55%5.65%-0.16%1 Year Performance20.00%27.91%36.75%15.05% Genflow Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GENFGenflow BiosciencesN/AGBX 1.80flatN/A+17.6%£6.30MN/A-180.005Gap DownOBIOndine BiomedicalN/AGBX 8.75+9.4%N/A-23.4%£24.26M£1.63M-291.67N/ANews CoverageGap UpOKYOOKYO PharmaN/AGBX 1.40-24.3%N/AN/A£23.24MN/A-140.007Gap DownAORAorTech InternationalN/AGBX 123.50-2.4%N/AN/A£19.99M£539,000.00-33.383HEMOHemogenyx PharmaceuticalsN/AGBX 1.34-3.6%N/A-30.8%£17.96MN/A-134.0014Gap DownRLMRealm TherapeuticsN/AGBX 11.50flatN/AN/A£13.41M£501,919.00-0.66N/ANSCINetScientificN/AGBX 53.50flatN/A+2.9%£12.81M£1.45M-486.3626ONCOncimmuneN/AGBX 15.19-2.0%N/A-4.3%£11.27M£1.21M-506.4752News CoverageGap DownOPTIOptiBiotix HealthN/AGBX 10.65+1.4%N/A-68.2%£10.43M£1.26M-355.001News CoverageGap DownSNGSynairgenN/AGBX 4.50-0.8%N/A-33.8%£9.06M£79,000.00-150.0034Gap UpHigh Trading VolumeCIZCizzle BiotechnologyN/AGBX 2.10flatN/A+11.2%£8.32M£25,000.00-210.004Gap Down Related Companies and Tools Related Companies OBI Competitors OKYO Competitors AOR Competitors HEMO Competitors RLM Competitors NSCI Competitors ONC Competitors OPTI Competitors SNG Competitors CIZ Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:GENF) was last updated on 11/2/2024 by MarketBeat.com Staff From Our PartnersMusk warns humanity: “Obsolete”The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genflow Biosciences plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Genflow Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GENF Stock Alerts